Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elad Goldberg

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Cell Communication and Signaling : CCS|April 15, 2024
Wnt signaling regulates chemokine production and cell migration of circulating human monocytesNatalie Zelikson, Shaina Ben, Michal Caspi, et al.
International Journal of Cardiology|November 29, 2023
The real-world safety of sacubitril / valsartan among older adults (≥75): A pharmacovigilance study from the FDA dataTsahi T Lerman, Noam Greenberg, Boris Fishman, et al.
Infectious Diseases and Therapy|July 20, 2021
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in Management of Nocardiosis: A Retrospective Study and Review of the LiteratureIli Margalit, Anat Yahav, Yaara Ben Ari, et al.
Infection|November 26, 2024
Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort studyNofar Hezkelo Attias, Tal Schlaeffer-Yosef, Itay Zahavi, et al.
Plos One|November 17, 2021
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort studyAdi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled TrialDafna Yahav, Erica Franceschini, Fidi Koppel, et al.
Gerontology|October 23, 2022
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative BacteremiaAdi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Cell Communication and Signaling : CCS|April 15, 2024
Wnt signaling regulates chemokine production and cell migration of circulating human monocytesNatalie Zelikson, Shaina Ben, Michal Caspi, et al.
International Journal of Cardiology|November 29, 2023
The real-world safety of sacubitril / valsartan among older adults (≥75): A pharmacovigilance study from the FDA dataTsahi T Lerman, Noam Greenberg, Boris Fishman, et al.
Infectious Diseases and Therapy|July 20, 2021
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in Management of Nocardiosis: A Retrospective Study and Review of the LiteratureIli Margalit, Anat Yahav, Yaara Ben Ari, et al.
Infection|November 26, 2024
Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort studyNofar Hezkelo Attias, Tal Schlaeffer-Yosef, Itay Zahavi, et al.
Plos One|November 17, 2021
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort studyAdi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled TrialDafna Yahav, Erica Franceschini, Fidi Koppel, et al.
Gerontology|October 23, 2022
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative BacteremiaAdi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Pageof 8